The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update DOI
Sabina Yasmin, Sumel Ashique, Tahreen Taj

и другие.

Brain Research, Год журнала: 2024, Номер unknown, С. 149400 - 149400

Опубликована: Дек. 1, 2024

Язык: Английский

Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases DOI
Vibhav Varshney,

Baneen C. Gabble,

Ashok Kumar Bishoyi

и другие.

Molecular Neurobiology, Год журнала: 2025, Номер unknown

Опубликована: Май 10, 2025

Язык: Английский

Процитировано

1

Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease DOI
Mohamed J. Saadh,

Faris Anad Muhammad,

Tuqa S. Alazzawi

и другие.

Molecular Neurobiology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 12, 2025

Язык: Английский

Процитировано

0

Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer’s Disease DOI

Subhasri Bogadi,

Mahendran Bhaskaran, Ravichandran Veerasamy

и другие.

Molecular Neurobiology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 16, 2025

Язык: Английский

Процитировано

0

Improving epilepsy management by targeting P2 × 7 receptor with ROS/electric responsive nanomicelles DOI Creative Commons
Zhaohong Kong, Jian Jiang, Min Deng

и другие.

Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)

Опубликована: Май 5, 2025

The intricate pathogenesis of epilepsy, characterized by abnormal neuronal discharges and neuroinflammation, underscores the critical involvement adenosine triphosphate (ATP)-P2X purinoceptor 7 (P2 × 7) receptor pathway in inflammation activation. To address this, a reactive oxygen species (ROS)/electric-responsive d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)-ferrocene-poloxamer nanomicelle (TFP@A) was engineered to deliver P2 antagonist A 438,079, aiming provide targeted therapeutic strategy for epilepsy management. study meticulously designed TFP@A precise drug delivery through various techniques including transmission electron microscopy (TEM), dynamic light scattering (DLS), high-performance liquid chromatography (HPLC). Cellular uptake blood-brain barrier (BBB) permeability were evaluated using fluorescein isothiocyanate (FITC)-labeled vitro brain endothelial cell line (bEnd.3) BBB model. In vivo distribution safety assessments conducted an mouse impact on investigated seizure analysis, electroencephalogram (EEG) recordings, inflammatory assessment. exhibited robust release profile under ROS electrical stimulation conditions. studies demonstrated its efficacy scavenging ROS, reducing oxidative stress, alleviating apoptosis models. Efficient cellular uptake, penetration, accumulation observed. Notably, effectively modulated 7R)-nucleotide-binding oligomerization domain-like family pyrin domain-containing 3 (NLRP3) pathway, inhibiting mediators promoting anti-inflammatory responses. loaded with showcases potential benefits suppressing NLRP3 inflammasome activation, mitigating microglial-neuron crosstalk, ameliorating symptoms, positioning it as promising avenue treatment.

Язык: Английский

Процитировано

0

Advancements in Stem Cell Research for Effective Therapies Against Alzheimer’s Disease: Current Investigation and Future Insight DOI
Abhinav Gupta, Arya Ghosh, Neelima Sharma

и другие.

Molecular Neurobiology, Год журнала: 2025, Номер unknown

Опубликована: Май 6, 2025

Язык: Английский

Процитировано

0

Reactive Oxygen Species in Neurodegenerative Disorders DOI
Arushi Sharma, Smriti Tiwari, Himanshu Sharma

и другие.

Advances in medical diagnosis, treatment, and care (AMDTC) book series, Год журнала: 2025, Номер unknown, С. 411 - 440

Опубликована: Янв. 3, 2025

Reactive oxygen species (ROS) are chemically reactive molecules containing oxygen. In the context of neurodegenerative disorders, ROS play a dual role while they necessary for normal cellular function, their overproduction can lead to oxidative stress, damaging neurons and contributing pathogenesis diseases such as Alzheimer's, Parkinson's, Huntington's, Amyotrophic Lateral Sclerosis (ALS). This book chapter explores mechanisms by which contributes neurodegeneration, including mitochondrial dysfunction, protein aggregation, inflammation. Additionally, we discuss current emerging therapeutic strategies aimed at modulating levels mitigating damage, antioxidants, gene therapy, lifestyle interventions. Understanding balance between production antioxidant defenses is crucial developing effective treatments diseases.

Язык: Английский

Процитировано

0

Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders DOI
Abhishek Gupta, Sumedha Gupta, Sidharth Mehan

и другие.

Molecular Neurobiology, Год журнала: 2025, Номер unknown

Опубликована: Май 9, 2025

Язык: Английский

Процитировано

0

Precision exosome engineering for neurological therapeutics: molecular mechanisms and targeted strategies DOI
Deepika Sharma, Shriyansh Srivastava, Molakpogu Ravindra Babu

и другие.

Molecular Biology Reports, Год журнала: 2025, Номер 52(1)

Опубликована: Май 30, 2025

Язык: Английский

Процитировано

0

The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update DOI
Sabina Yasmin, Sumel Ashique, Tahreen Taj

и другие.

Brain Research, Год журнала: 2024, Номер unknown, С. 149400 - 149400

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

2